IGF1 and neoplasm: They assessed circulating interleukin-6 (IL-6), VEGF, fasting insulin, and tumor expression of insulin-like growth factor-1 receptor (IGF-1R), insulin receptor (IR), insulin-like growth factor-1 (IGF-1), and RAGE markers before surgery and 6 months after tumor surgery.